Switch to:
Myriad Genetics Inc  (NAS:MYGN) Total Current Assets: \$325.6 Mil (As of Sep. 2017)

Total current assets includes Cash And Cash Equivalents, Accounts Receivable, Total Inventories, and Other Current Assets. Myriad Genetics Inc's total current assets for the quarter that ended in Sep. 2017 was \$325.6 Mil.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Total Current Assets 483.99 322.40 283.60 314.50 317.10

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Total Current Assets 322.90 341.60 348.30 317.10 325.60

Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Myriad Genetics Inc's Total Current Assets for the fiscal year that ended in Jun. 2017 is calculated as

 Total Current Assets = Cash And Cash Equivalents + Accounts Receivable + Total Inventories + Total Current Assets = 150.7 + 105.6 + 42.2 + 18.6 = 317.1

Myriad Genetics Inc's Total Current Assets for the quarter that ended in Sep. 2017 is calculated as

 Total Current Assets = Cash And Cash Equivalents + Accounts Receivable + Total Inventories + Total Current Assets = 148.3 + 113.2 + 38.9 + 25.2 = 325.6

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Myriad Genetics Inc's Liquidation Value for the quarter that ended in Sep. 2017 is

 Liquidation value = Cash And Cash Equivalents - Total Liabilities + (0.75 * Accounts Receivable) + (0.5 * Total Inventories) = 148.3 - 357.4 + 0.75 * 113.2 + 0.5 * 38.9 = -104.8

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

From the Internet

###### AmerisourceBergen to Take Over H. D. Smith for \$815 Million

- Zacks 2017-11-22 08:14:00

###### Rising Costs Hurt Henry Schein, End-Market Trends a Tailwind

- Zacks 2017-11-22 07:53:00

###### Teladoc, Inc. (TDOC) Jumps: Stock Rises 10.5%

- Zacks 2017-11-22 07:43:00

###### Medtronic Wins FDA Nod for Azure Pacemakers, Grows in CVG

- Zacks 2017-11-21 08:46:00

###### DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

- Zacks 2017-11-21 05:44:00

###### McKesson Gains From Distribution Business Amid Pricing Woes

- Zacks 2017-11-21 04:54:00

###### Haemonetics (HAE) at 52-Week High: What's Driving the Stock?

- Zacks 2017-11-20 15:09:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)